ABSTRACT How has funding to developing countries for health improvement changed in the wake of the global financial crisis? The question is vital for policy making, planning, and advocacy purposes in donor and recipient countries alike. We measured the total amount of financial and in-kind assistance that flowed from both public
D evelopment assistance for health increased rapidly over the past decade, but its annualized rate of growth slowed following the global financial crisis.
1,2 Some economists have predicted that foreign assistance to developing countries will decline in the wake of the recession. 3, 4 In fact, in November 2011 the Global Fund to Fight AIDS, Tuberculosis, and Malaria (commonly known as the Global Fund) announced that it would make no new grants until 2014, in large part because of depressed donations attributed to the global financial crisis. 5 However, some researchers have found that assistance for health may be more resilient than other types of aid, because aid for health did not decrease during previous downturns. 6, 7 In Financing Global Health 2010: Development Assistance and Country Spending in Economic Uncertainty, 1 we noted that it was unsurprising that funding for health in developing countries con-tinued to rise, because it was driven largely by financial contributions from governments that were committed before the recession began and were spread over multiple years. Nevertheless, ongoing economic distress creates uncertainty regarding future levels of development assistance for health. [8] [9] [10] Our findings quantify the reduced growth of development assistance for health in the wake of the global recession and track its slower but continued rise through 2011.
We measured the total amount of financial and in-kind assistance that flowed from development organizations, or channels of assistance, to improve health in developing countries during the period 1990-2011. We tracked assistance for health from both public and private channels such as bilateral organizations of member countries of the Organization for Economic Cooperation and Development's Development Assistance Committee; nongovernmental organizations and foundations based in the United States; public-private partnerships such as the Global Fund and the GAVI Alliance (formerly the Global Alliance for Vaccines and Immunization); and institutions such as the World Bank and other regional development banks.
A major challenge in tracking development assistance for health comes from the long time lag between disbursements of funds and publication of data about these disbursements. We overcame this challenge by using budget documents, financial statements, and correspondence with donors to produce preliminary estimates of development assistance for health for the years lacking published disbursement data. Despite an inevitable margin of error in our prediction, the validity and utility of these estimates is supported by the fact that our preliminary estimate of total development assistance for health in 2009 was within 1 percent of the estimate generated this year from actual disbursement data. 1 
Study Data And Methods
We estimated development assistance for health for the years 1990-2011. All estimates are presented in constant 2009 US dollars. The data for the years 1990-2009 reflect disbursements, while the numbers for 2010 and 2011 are preliminary estimates.
We defined development assistance for health as financial and in-kind contributions made by channels of development assistance-that is, by institutions whose primary purpose is providing development assistance to improve health in developing countries. The estimates included general health-sector support, which is defined as funds that can be used for any area of the health sector, as well as all disease-specific contributions. The definition excluded support for related sectors such as primary education, water and sanitation, and food security.
A key difference between our definition of development assistance for health and global health financing tracked in other studies is that we included loans from the International Bank for Reconstruction and Development, a lending arm of the World Bank, and assistance from private entities such as nongovernment organizations. 6, 11 A forthcoming article by Karen Grépin and colleagues contrasts the different types of health assistance tracked in Financing Global Health 2010 to those tracked in other global health financing databases. 1, 12 To generate estimates from the years 1990-2009, we tracked, where possible, all development assistance for health reported by public and private channels of aid. We reviewed both the revenue and disbursement data for each of these channels. The data came from annual reports, government documents, audited financial statements, tax forms, and data sets provided by public and private donors.
To ensure that we did not double-count the same assistance dollars flowing through multiple channels, we subtracted transfers between channels tracked by our study. This process enabled us to segment total assistance by source, channel, and type of funding.
Few channels of assistance that we tracked provided disbursement data for 2010 and 2011. To generate preliminary estimates for those years, we collected the most current data available from sources such as budget documents and financial statements, and we estimated the relationship between budgeted amounts or revenue raised and future expenditures. In some cases we obtained data on 2010 disbursements and estimated 2011 disbursements from correspondence with channels of assistance. The core methods used to generate our results are described in Financing Global Health 2010.
1
These preliminary estimates might be overestimates if donors have failed to honor their commitments, as indicated by the Global Fund's recent announcement of its plans to discontinue new grant funding for the next two years as a result of ongoing economic troubles in donor countries. 5 The uncertainty surrounding our preliminary estimates of development assistance for health in 2010 and 2011 could be avoided if all channels had provided timely disbursement data.
Several new data sources were incorporated into this year's analysis. Among them, we included health spending from some of the largest nongovernmental organizations in the United
States for the years 1999-2010, which allowed us to improve our estimates of development assistance for health flowing through these channels. Also, to strengthen our preliminary estimates, we incorporated into our data set budget data on foreign assistance from South Korea and the Netherlands, along with revised 2010 spending data from sources such as the GAVI Alliance and the Bill & Melinda Gates Foundation. As a result of these new data, our estimates of assistance from these particular sources are notably different from those in our 2010 report. 1 Our approach did not account for private donations from countries outside of the United States. This is because of the lack of standardized data on private non-US donations. A study of overall philanthropic contributions from countries on the Organization for Economic Cooperation and Development's Development Assistance Committee, excluding the United States, indicated that these funds were 60 percent lower than private development assistance for health from the United States in 2008. 13 
Study Results
We estimate that development assistance for health grew by 4 percent each year from 2009 to 2011, reaching a total of $27.73 billion over the two years. This compares to a growth rate of 17 percent between 2007 and 2008. Thus, although development assistance for health continued to grow, it did so slowly. Exhibit 1 reports development assistance for health from 1990 to 2011 by channel of assistance. The new growth rates observed since 2009 are comparable to those observed during the 1990s.
Exhibit 2 summarizes the changes in development assistance for health by channel of assistance from 2010 to 2011. For example, the percentage change from bilateral channels was relatively small, but its contribution to development assistance for health was the second largest in absolute terms.
The institution from 2010 to 2011 accounted for $797 million of the growth in total development assistance for health in that year. This scale-up in financing appears to be part of the World Bank's response to the global economic crisis to help developing countries stimulate their economies and provide social safety nets for their citizens. 14, 15 The scaling up by the International Bank for Reconstruction and Development marks a shift in the landscape of development assistance for health because this funding is primarily targeted toward middle-income countries instead of lowincome countries. 16 The bank provides aid for health in the form of loans, whereas many other channels of assistance offer grants that do not have to be repaid. 16 There is some debate about whether the bank's loans should be counted as development assistance for health. Although some researchers exclude the loans, 11 we chose to include them, to maintain consistency with previous studies of health assistance for developing countries.
1,2 If these loans had been excluded from our estimates, then total development assistance for health would have increased only 1 percent between 2010 and 2011 instead of 4 percent (an increase of $269.75 million instead of $1.07 billion).
At the same time that the World Bank has increased development assistance for health through its International Bank for Reconstruction and Development, an opposite trend has prevailed in its fund for poor countries, the International Development Association. This fund primarily provides interest-free credits and grants to the poorest countries. 17 Development assistance for health from the fund has decreased since 2006. However, it recently experienced substantial fund-raising success at its sixteenth replenishment in 2010. 18 Therefore, it will be important to examine the replenishment's impact on the fund's assistance in the future.
Development assistance for health channeled through bilateral agencies was the main driver of growth in health funding for developing coun- velopment assistance for health. However, bilateral channels were still the second-largest contributors to the total growth of funding assistance for health from 2010 to 2011.
The annualized growth rate of development assistance for health channeled through UN agencies slowed after the recession, from 6 The real value of services provided by UN agencies might be overstated when measured in US dollars. For example, the World Health Organization receives its revenue in US dollars but pays its headquarters staff in Swiss francs. 19 One US dollar was worth 1.20 Swiss francs in 2007 but only 0.92 Swiss francs in 2011. Therefore, the number of staff hours the organization can purchase with a given amount of revenue has declined substantially over this time. This is noteworthy because staff salaries are a large part of the World Health Organization's budget. 20 Slower growth rates of development assistance for health channeled through UN agencies are not a new phenomenon. The agencies' share of total development assistance for health decreased from 21 percent in 2002 to 14 percent in 2011, principally because other channels grew faster.
As UN agencies' dominance has declined, newer actors such as the GAVI Alliance and the Global Fund have emerged and channeled increasingly larger shares of development assistance for health to developing countries. The The Global Fund's recent announcement about its plans to scale back funding because of reduced revenue indicates that certain donors continued to disburse less than they had committed in 2011. 5 
Discussion And Policy Implications
Our estimates reveal four trends that have important implications for global health financing.
First, multilateral development assistance for health continued to grow through 2011, but there have been shifts in both the recipients and the purpose of this assistance. The changes stem in part from the expanded role of the International Bank for Reconstruction and Development because this channel provides loans primarily to middle-income countries for the purpose of health improvement and broader economic stimulus. In contrast, development assistance for health from the fund of the World Bank for the poorest countries, the International Development Association-which provides grants and interest-free, long-term credits to lowincome countries-has decreased.
Second, there has been a shift in bilateral development assistance for health. Between 2002 and 2010, this was the main source of the massive increases in assistance for health. But in 2011, growth from this channel slowed to its lowest annualized rate since 2001. Consequently, the prospect of renewed expansion of development assistance for health at recently observed growth rates seems unlikely. Also, much of the slowdown in bilateral assistance for health stems from the slowdown of assistance from the United States. The slowdown may indicate that recipients of the largest US health assistance funds, such as countries in the President's Emergency Plan for AIDS Relief partnership framework, will feel the effects of the slowdown most acutely.
Third, stagnation in UN funding may pose risks to several health focus areas in which these channels play an important role. UN agencies collectively represent a large fraction of funding to several priority health areas. The three areas most dependent on UN support are maternal and child health (the United Nations provided 37 percent of total development assistance for health for this area in 2009), noncommunicable diseases (25 percent), and tuberculosis (16 percent). It is unclear how well other channels are positioned to reallocate their funding to these areas, which may be problematic for the achieve-ment of Millennium Development Goals if UN development assistance for health continues its current trend.
Fourth, newer actors such as the GAVI Alliance and the Global Fund have channeled large shares of total development assistance for health over the past decade. The GAVI Alliance is still experiencing rapid growth, but the Global Fund's growth appears to have stalled.
The GAVI Alliance's success in securing a steady stream of financing despite economic hardship in donor countries could partly be a result of the long-term funding provided by the International Finance Facility for Immunisation. 21 Meanwhile, the Global Fund's share of total development assistance for health increased quickly between its establishment in 2002 and 2010, but a recent report from its High-Level Independent Review Panel suggests an institutional shift in focus from prioritizing the speed and size of disbursements to ensuring the effectiveness of and accountability for grants. 22 Given the panel's recommendations and the Global Fund's announcement that cuts in donor funding have made it necessary to stop providing new grants, 5 development assistance for health from the Global Fund might not expand as rapidly as it has in the past.
As economic hardship persists in many donor countries, growth in development assistance for health has slowed but continues to rise overall. Because assistance for health is considered to be critical for meeting the Millennium Development Goal targets, 23 
NOTES
In this month's Health Affairs, Katherine Leach-Kemon and coauthors report on their measure of the total amount financial and in-kind assistance that flowed from both public and private sources to improve health in developing countries in the years 1990 to 2011. Their goal was to assess the impact of the global financial crisis on funding for health improvement in these countries. The authors discovered that development assistance for health continued to grow after the economic downturn began in 2008, but the rate of growth slowed to 4 percent from 2009 to 2011.
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